November 5, 2013
Masumi Minaguchi A non-governmental drug damage watch group filed a criminal complaint with Tokyo prosecutors over Novartis Pharma’s antihypertensive Diovan (valsartan) on November 1, alleging that the pharmaceutical maker dispersed misinformation by using manipulated clinical trial data in its advertising...read more